Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry.
Armenia D, Spagnuolo V, Bellocchi MC, Galli L, Duca L, Marchegiani G, Clemente T, Carioti L, Lolatto R, Calza L, Celesia BM, Cascio A, Francisci D, Saracino A, Torti C, Zazzi M, Castagna A, Santoro MM; PRESTIGIO Study Group. Armenia D, et al. J Antimicrob Chemother. 2024 Sep 3;79(9):2354-2363. doi: 10.1093/jac/dkae236. J Antimicrob Chemother. 2024. PMID: 39004997
Virological Effectiveness of Dolutegravir Plus Darunavir in People with Multi-Drug-Resistant HIV: Data from the PRESTIGIO Registry.
Lagi F, Bellomo M, Lolatto R, Ducci F, Kiros ST, Spagnuolo V, Borjesson RP, Clemente T, Calza L, Feasi M, Focà E, Giacomelli A, Gulminetti R, Menzaghi B, Castagna A, On Behalf Of The Prestigio Study Group. Lagi F, et al. Among authors: borjesson rp. Viruses. 2025 Aug 24;17(9):1158. doi: 10.3390/v17091158. Viruses. 2025. PMID: 41012586 Free PMC article.
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry.
Clemente T, Diotallevi S, Minisci D, Di Biagio A, Lolatto R, Attala L, Cenderello G, Siribelli A, Muccini C, Lo Caputo S, Tavio M, Papaioannu Borjesson R, Giacomelli A, Castagna A, Spagnuolo V; PRESTIGIO Study Group. Clemente T, et al. J Antimicrob Chemother. 2025 Mar 3;80(3):731-737. doi: 10.1093/jac/dkae465. J Antimicrob Chemother. 2025. PMID: 39727173
The INfectious DIsease REgistry BIObank (INDI-REBIO): protocol for the design and implementation of a single-centre, prospective registry and biobank in a tertiary care centre in Italy for advancing infectious disease research.
Ripa M, Galli L, Cinque P, Nozza S, Spagnuolo V, Tassan Din C, Guffanti M, Lolatto R, Piromalli G, Carletti S, Locatelli M, Sanvito F, Ponzoni M, Cantarelli E, Tresoldi C, Castagna A; INDI-REBIO Study Group. Ripa M, et al. BMJ Open. 2025 Aug 12;15(8):e091113. doi: 10.1136/bmjopen-2024-091113. BMJ Open. 2025. PMID: 40803735 Free PMC article.